| HGNC Family | Basic helix-loop-helix proteins (BHLH) |
| Name | v-myc avian myelocytomatosis viral oncogene homolog |
| Description | This gene is a proto-oncogene and encodes a nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. The encoded protein forms a heterodimer with the related transcription factor MAX. This complex binds to the E box DNA consensus sequence and regulates the transcription of specific target genes. Amplification of this gene is frequently observed in numerous human cancers. Translocations involving this gene are associated with Burkitt lymphoma and multiple myeloma in human patients. There is evidence to show that translation initiates both from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site, resulting in the production of two isoforms with distinct N-termini. [provided by RefSeq, Aug 2017] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe MYC oncogene encodes a potent transcription factor that orchestrates diverse gene‐expression programs essential for cell proliferation, cell cycle progression, DNA replication, and apoptosis. MYC directly binds to and regulates the promoters of a large repertoire of genes—including those encoding core cell cycle regulators, transcriptional machinery subunits (across RNA polymerases I, II, and III), and key microRNAs that in turn fine‐tune targets such as E2F1 and other proliferation‐ and apoptosis‐linked factors. In addition, alternative translational initiation events yield distinct MYC protein isoforms, and MYC itself directly interacts with pre‐replicative complexes to modulate replication origin activity. Collectively, these mechanisms underscore MYC’s central role as a master regulator of transcription and cell cycle control in both normal and malignant cells."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its transcriptional functions, MYC reprograms cellular metabolism to support the energetic and biosynthetic demands of rapid proliferation. It does so by, for example, repressing specific microRNAs to upregulate mitochondrial glutaminase—thereby stimulating glutamine catabolism—and by modulating alternative splicing events that favor the expression of the PKM2 isoform, which reinforces aerobic glycolysis. MYC also drives mitochondrial biogenesis and alters proline metabolism while collaborating with hypoxia‐responsive factors to shift the balance between oxidative phosphorylation and glycolysis. Such metabolic reprogramming not only meets the biosynthetic requirements of growing cells but also creates vulnerabilities under nutrient stress."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "27"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMoreover, MYC plays pivotal roles in modulating cell identity, stemness, and the tumor microenvironment. Its ectopic expression is a key component in cellular reprogramming to induced pluripotency, while in malignant contexts MYC directly upregulates immune checkpoint proteins such as CD47 and PD‐L1 to facilitate immune evasion. In several tumor types—including diffuse large B‐cell lymphoma, Burkitt’s lymphoma, and medulloblastoma—long‐range chromatin interactions and aberrant regulatory loops (often involving noncoding RNAs) lead to deregulated MYC expression that correlates with aggressive clinical behavior. These observations have spurred therapeutic strategies that target MYC indirectly (via bromodomain inhibitors, spliceosome disruption, or interference with associated noncoding RNAs) as well as efforts to use MYC status as a prognostic biomarker in diverse cancers."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "28", "end_ref": "41"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kathryn A O'Donnell, Erik A Wentzel, Karen I Zeller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "c-Myc-regulated microRNAs modulate E2F1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature03677"}], "href": "https://doi.org/10.1038/nature03677"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15944709"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15944709"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Tsung-Cheng Chang, Duonan Yu, Yun-Sil Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Widespread microRNA repression by Myc contributes to tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.2007.30"}], "href": "https://doi.org/10.1038/ng.2007.30"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18066065"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18066065"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Peter B Rahl, Charles Y Lin, Amy C Seila, et al. "}, {"type": "b", "children": [{"type": "t", "text": "c-Myc regulates transcriptional pause release."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2010.03.030"}], "href": "https://doi.org/10.1016/j.cell.2010.03.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20434984"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20434984"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Omid Vafa, Mark Wade, Suzanne Kern, et al. "}, {"type": "b", "children": [{"type": "t", "text": "c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s1097-2765(02)00520-8"}], "href": "https://doi.org/10.1016/s1097-2765(02"}, {"type": "t", "text": "00520-8) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12049739"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12049739"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Stella Pelengaris, Mike Khan, Gerard Evan "}, {"type": "b", "children": [{"type": "t", "text": "c-MYC: more than just a matter of life and death."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Rev Cancer (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nrc904"}], "href": "https://doi.org/10.1038/nrc904"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12360279"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12360279"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Zirong Li, Sara Van Calcar, Chunxu Qu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1332764100"}], "href": "https://doi.org/10.1073/pnas.1332764100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12808131"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12808131"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Azadeh Arabi, Siqin Wu, Karin Ridderstråle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb1225"}], "href": "https://doi.org/10.1038/ncb1225"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15723053"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15723053"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Carla Grandori, Natividad Gomez-Roman, Zoe A Felton-Edkins, et al. "}, {"type": "b", "children": [{"type": "t", "text": "c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb1224"}], "href": "https://doi.org/10.1038/ncb1224"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15723054"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15723054"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "David Dominguez-Sola, Carol Y Ying, Carla Grandori, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Non-transcriptional control of DNA replication by c-Myc."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature05953"}], "href": "https://doi.org/10.1038/nature05953"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17597761"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17597761"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "S R Hann, M W King, D L Bentley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (1988)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/0092-8674(88)90507-7"}], "href": "https://doi.org/10.1016/0092-8674(88"}, {"type": "t", "text": "90507-7) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "3277717"}], "href": "https://pubmed.ncbi.nlm.nih.gov/3277717"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Michael T Hemann, Anka Bric, Julie Teruya-Feldstein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature03845"}], "href": "https://doi.org/10.1038/nature03845"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16094360"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16094360"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Karen I Zeller, XiaoDong Zhao, Charlie W H Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Global mapping of c-Myc binding sites and target gene networks in human B cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0604129103"}], "href": "https://doi.org/10.1073/pnas.0604129103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17093053"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17093053"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Teresa Palomero, Wei Keat Lim, Duncan T Odom, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0606108103"}], "href": "https://doi.org/10.1073/pnas.0606108103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17114293"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17114293"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Nikita Popov, Michael Wanzel, Mandy Madiredjo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The ubiquitin-specific protease USP28 is required for MYC stability."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb1601"}], "href": "https://doi.org/10.1038/ncb1601"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17558397"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17558397"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Mohit Sachdeva, Shoumin Zhu, Fangting Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p53 represses c-Myc through induction of the tumor suppressor miR-145."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0808042106"}], "href": "https://doi.org/10.1073/pnas.0808042106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19202062"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19202062"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Li Ma, Jennifer Young, Harsha Prabhala, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb2024"}], "href": "https://doi.org/10.1038/ncb2024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20173740"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20173740"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Tiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The spliceosome is a therapeutic vulnerability in MYC-driven cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature14985"}], "href": "https://doi.org/10.1038/nature14985"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26331541"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26331541"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Ping Gao, Irina Tchernyshyov, Tsung-Cheng Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature07823"}], "href": "https://doi.org/10.1038/nature07823"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19219026"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19219026"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Mark M Pomerantz, Nasim Ahmadiyeh, Li Jia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.403"}], "href": "https://doi.org/10.1038/ng.403"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19561607"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19561607"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Charles J David, Mo Chen, Marcela Assanah, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature08697"}], "href": "https://doi.org/10.1038/nature08697"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20010808"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20010808"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Feng Li, Yunyue Wang, Karen I Zeller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.25.14.6225-6234.2005"}], "href": "https://doi.org/10.1128/MCB.25.14.6225-6234.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15988031"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15988031"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Mariia O Yuneva, Teresa W M Fan, Thaddeus D Allen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2011.12.015"}], "href": "https://doi.org/10.1016/j.cmet.2011.12.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22326218"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22326218"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Mariia Yuneva, Nicola Zamboni, Peter Oefner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.200703099"}], "href": "https://doi.org/10.1083/jcb.200703099"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17606868"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17606868"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Wei Liu, Anne Le, Chad Hancock, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1203244109"}], "href": "https://doi.org/10.1073/pnas.1203244109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22615405"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22615405"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Jung-whan Kim, Ping Gao, Yen-Chun Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00440-07"}], "href": "https://doi.org/10.1128/MCB.00440-07"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17785433"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17785433"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Minori Koshiji, Yukio Kageyama, Erin A Pete, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HIF-1alpha induces cell cycle arrest by functionally counteracting Myc."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.emboj.7600196"}], "href": "https://doi.org/10.1038/sj.emboj.7600196"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15071503"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15071503"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Kyung-Min Lee, Jennifer M Giltnane, Justin M Balko, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2017.09.009"}], "href": "https://doi.org/10.1016/j.cmet.2017.09.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28978427"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28978427"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "In-Hyun Park, Rui Zhao, Jason A West, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reprogramming of human somatic cells to pluripotency with defined factors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature06534"}], "href": "https://doi.org/10.1038/nature06534"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18157115"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18157115"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Stephanie C Casey, Ling Tong, Yulin Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MYC regulates the antitumor immune response through CD47 and PD-L1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.aac9935"}], "href": "https://doi.org/10.1126/science.aac9935"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26966191"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26966191"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Jian-Feng Xiang, Qing-Fei Yin, Tian Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cr.2014.35"}], "href": "https://doi.org/10.1038/cr.2014.35"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24662484"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24662484"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Heike Horn, Marita Ziepert, Claudia Becher, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2012-06-435842"}], "href": "https://doi.org/10.1182/blood-2012-06-435842"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23335369"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23335369"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Tina Marie Green, Ken H Young, Carlo Visco, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2011.41.4342"}], "href": "https://doi.org/10.1200/JCO.2011.41.4342"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22665537"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22665537"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Gabriel Bretones, M Dolores Delgado, Javier León "}, {"type": "b", "children": [{"type": "t", "text": "Myc and cell cycle control."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbagrm.2014.03.013"}], "href": "https://doi.org/10.1016/j.bbagrm.2014.03.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24704206"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24704206"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Sharon Barrans, Simon Crouch, Alex Smith, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2009.26.3947"}], "href": "https://doi.org/10.1200/JCO.2009.26.3947"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20498406"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20498406"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Elizabeth M Molyneux, Rosemary Rochford, Beverly Griffin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Burkitt's lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lancet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/S0140-6736(11)61177-X"}], "href": "https://doi.org/10.1016/S0140-6736(11"}, {"type": "t", "text": "61177-X) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22333947"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22333947"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Jennifer A Mertz, Andrew R Conery, Barbara M Bryant, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting MYC dependence in cancer by inhibiting BET bromodomains."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1108190108"}], "href": "https://doi.org/10.1073/pnas.1108190108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21949397"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21949397"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Yoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2010.28.5148"}], "href": "https://doi.org/10.1200/JCO.2010.28.5148"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21098324"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21098324"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Yuen-Yi Tseng, Branden S Moriarity, Wuming Gong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PVT1 dependence in cancer with MYC copy-number increase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature13311"}], "href": "https://doi.org/10.1038/nature13311"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25043044"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25043044"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Patricia Sancho, Emma Burgos-Ramos, Alejandra Tavera, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Metab (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cmet.2015.08.015"}], "href": "https://doi.org/10.1016/j.cmet.2015.08.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26365176"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26365176"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Nathalie A Johnson, Graham W Slack, Kerry J Savage, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2011.41.0985"}], "href": "https://doi.org/10.1200/JCO.2011.41.0985"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22851565"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22851565"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Shimin Hu, Zijun Y Xu-Monette, Alexander Tzankov, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2012-10-460063"}], "href": "https://doi.org/10.1182/blood-2012-10-460063"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23449635"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23449635"}]}]}]}
|
| Synonyms | C-MYC, MYCC, BHLHE39, MRTL |
| Proteins | MYC_HUMAN |
| NCBI Gene ID | 4609 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MYC has 36,080 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 152 datasets.
Click the + buttons to view associations for MYC from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by MYC gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MYC gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of MYC gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MYC gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of MYC gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of MYC gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MYC gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving MYC protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of MYC gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MYC gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MYC gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of MYC gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MYC gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of MYC gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene Mutation Profiles | cell lines with MYC gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with MYC protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with MYC gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MYC gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MYC gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of MYC gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with MYC gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with MYC gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of MYC gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MYC gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing MYC protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing MYC protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing MYC protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing MYC protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with MYC protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with MYC protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing MYC protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with MYC gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with MYC gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with MYC gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of MYC protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DEPOD Substrates of Phosphatases | phosphatases that dephosphorylate MYC protein from the curated DEPOD Substrates of Phosphatases dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for MYC protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving MYC gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving MYC gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores | diseases associated with MYC gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with MYC gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with MYC gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with MYC gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with MYC gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with MYC gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for MYC protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MYC gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MYC gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MYC gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing MYC from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with MYC gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with MYC gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of MYC gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MYC gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MYC from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of MYC gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MYC gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of MYC gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MYC gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MYC gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of MYC gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving MYC gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving MYC gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving MYC gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing MYC protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing MYC protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing MYC protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by MYC gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by MYC gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by MYC gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MYC gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of MYC gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MYC gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of MYC gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with MYC gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of MYC gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of MYC gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of MYC gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of MYC protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MYC gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with MYC gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for MYC from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP ASCT+B Annotations | cell types associated with MYC gene from the HuBMAP ASCT+B dataset. | |
| HuBMAP ASCT+B Augmented with RNA-seq Coexpression | cell types associated with MYC gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with MYC gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MYC gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by MYC gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for MYC protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of MYC gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of MYC gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MYC gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate MYC protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways | pathways involving MYC protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving MYC protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate MYC protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MYC gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of MYC gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with MYC gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MYC gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of MYC gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of MYC gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MYC gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing MYC protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain MYC protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MYC gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting MYC gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MYC gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of MYC gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by MYC gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for MYC from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of MYC gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of MYC gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with MYC gene from the curated OMIM Gene-Disease Associations dataset. | |
| PANTHER Pathways | pathways involving MYC protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for MYC from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MYC gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of MYC gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving MYC protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving MYC protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with MYC protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Phosphosite-Disease Associations | diseases associated with MYC protein from the curated PhosphoSitePlus Phosphosite-Disease Associations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate MYC protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| PID Pathways | pathways involving MYC protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving MYC protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving MYC protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MYC gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MYC gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MYC gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MYC gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MYC gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MYC gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of MYC gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MYC gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MYC gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of MYC gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of MYC protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands | ligand (protein) perturbations changing phosphorylation of MYC protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of MYC gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of MYC gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of MYC gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of MYC gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of MYC gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of MYC protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MYC protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of MYC protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MYC protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with MYC protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with MYC protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| Virus MINT Protein-Viral Protein Interactions | interacting viral proteins for MYC from the Virus MINT Protein-Viral Protein Interactions dataset. | |
| Virus MINT Protein-Virus Interactions | viruses interacting with MYC from the Virus MINT Protein-Virus Interactions dataset. | |
| WikiPathways Pathways 2014 | pathways involving MYC protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving MYC protein from the WikiPathways Pathways 2024 dataset. | |